R, B., A, B., M, C., M, G., & I, M. (2022). Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel. Neurologia, 37(7), 608. https://doi.org/10.1016/j.nrleng.2021.10.002
Chicago Style (17th ed.) CitationR, Baviera-Muñoz, Buigues-Lafuente A, Campins-Romeu M, Garcés-Sánchez M, and Martinez-Torres I. "Refractory Status Epilepticus Due to Vitamin B6 Deficit in a Parkinson's Disease Patient in Treatment with Levodopa/carbidopa Intestinal Gel." Neurologia 37, no. 7 (2022): 608. https://doi.org/10.1016/j.nrleng.2021.10.002.
MLA (9th ed.) CitationR, Baviera-Muñoz, et al. "Refractory Status Epilepticus Due to Vitamin B6 Deficit in a Parkinson's Disease Patient in Treatment with Levodopa/carbidopa Intestinal Gel." Neurologia, vol. 37, no. 7, 2022, p. 608, https://doi.org/10.1016/j.nrleng.2021.10.002.